OKUR (STOCKS)
OnKure Therapeutics, Inc. Class A Common Stock
$4.605000
+0.155000 (+3.48%)
Prev close: $4.450000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Nicholas A. Saccomano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $62.90M
- Employees
- 46
- P/E (TTM)
- -1.01
- P/B (TTM)
- 1.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.99 | $-1.18 | +0.1850 | +15.74% |
|
Sep 2025 (Q3)
|
$-1.09 | $-1.22 | +0.1320 | +10.80% |
|
Jun 2025 (Q2)
|
$-1.14 | $-1.27 | +0.1330 | +10.45% |
|
Mar 2025 (Q1)
|
$-1.19 | $-1.49 | +0.2992 | +20.09% |
Financial Statements
| Revenues | $3.43M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $66.38M |
| Operating Expenses | $62.95M |
| Research and Development | $48.26M |
| Other Operating Expenses | $14.69M |
| Operating Income/Loss | -$62.95M |
| Income/Loss From Continuing Operations After Tax | -$59.52M |
| Income/Loss From Continuing Operations Before Tax | $3.43M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Income/Expense After Provision For Losses | $3.43M |
| Interest Income/Expense Operating, Net | $3.43M |
| Net Income/Loss | -$59.52M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$59.52M |
| Net Income/Loss Available To Common Stockholders, Basic | -$59.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$4.40 |
| Diluted Earnings Per Share | -$4.40 |
| Basic Average Shares | 13,515,915 |
| Diluted Average Shares | 13,515,915 |
| Assets | $62.12M |
| Current Assets | $60.84M |
| Noncurrent Assets | $1.28M |
| Fixed Assets | $618.00K |
| Other Non-current Assets | $660.00K |
| Liabilities | $5.93M |
| Current Liabilities | $5.92M |
| Accounts Payable | $1.43M |
| Wages | $2.69M |
| Other Current Liabilities | $1.80M |
| Noncurrent Liabilities | $12.00K |
| Equity | $56.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $56.18M |
| Liabilities And Equity | $62.12M |
| Net Cash Flow From Operating Activities | -$51.83M |
| Net Cash Flow From Operating Activities, Continuing | -$51.83M |
| Net Cash Flow From Investing Activities | -$46.00K |
| Net Cash Flow From Investing Activities, Continuing | -$46.00K |
| Net Cash Flow From Financing Activities | $163.00K |
| Net Cash Flow From Financing Activities, Continuing | $163.00K |
| Net Cash Flow | -$51.71M |
| Net Cash Flow, Continuing | -$51.71M |
| Comprehensive Income/Loss | -$59.52M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$59.52M |
| Other Comprehensive Income/Loss | $0.00 |